Home » Stocks » GHRS

GH Research PLC (GHRS)

GH Research PLC will go public soon. The estimated IPO date is June 25, 2021.
Stock Price: $14.00 - $16.00
Current IPO price range
Market Cap 732.81M
Revenue (ttm) n/a
Net Income (ttm) -1.58M
Shares Out 48.85M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

GH Research PLC has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC

About GHRS

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Our initial focus is on developing our novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Patients with Major Depressive Disorder, or MDD, who have not adequately responded to adequate therapy clearly have harder-to-treat depression, generally referred to as TRD. There is no consensus definition for ... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Jun 25, 2021
CEO
Theis Terwey
Employees
8
Stock Exchange
NASDAQ
Ticker Symbol
GHRS
Full Company Profile

Financial Performance

Financial Statements